Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03664609 · ClinicalTrials.gov registry record
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
A clinical trial of Parkinson Disease and Essential Tremor, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 19
- Study locations
NCT03664609 is a study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 5,000 participants, roughly in line with the 5,310-participant average among 297 other Parkinson Disease trials with a reported enrollment target. The trial reports 19 study locations across 9 states.
The verdict
NCT03664609, a study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 19
- Study locations
Study Summary
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation
Study Locations (19)
Other
- AZ St. Lucas - Ghent
- AZ Delta - Roeselare
- Hopital Fondation Adolphe de Rothschild - Paris
- Uniklinik Köln - Cologne
- Universitaetsklinikum Dusseldorf - Düsseldorf
- Uniklinikum Jena - Jena
- Universitaetsklinikum Schleswig-Holstein - Lübeck
- Universitaetsklinikum Wuerzburg - Würzburg
- Fondazione Istituto Neurologico Casimiro Mondino - Pavia
- Hospital Virgen Del Rocio - Seville
Florida
- University of Miami Hospital - Miami
- University of South Florida - Tampa
Arizona
- St. Joseph's Hospital & Medical Center - Phoenix
California
- University of California, San Francisco - San Francisco
Idaho
- St. Luke's Regional Medical Center - Boise
New York
- Albany Medical Center - Albany
North Carolina
- Wake Forest University School of Medicine - Winston-Salem
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03664609
The ClinicalTrials.gov registry entry for NCT03664609 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 5,310-participant average among 297 other Parkinson Disease trials with a reported enrollment target. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.
NCT03664609 reports 19 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT03664609 about?
NCT03664609 is a clinical study titled "Deep Brain Stimulation (DBS) Retrospective Outcomes Study". The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
What is the current status of trial NCT03664609?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2019-03-12. Estimated completion is 2028-12.
What conditions does trial NCT03664609 study?
This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia.
What interventions are being tested in trial NCT03664609?
The interventions under investigation include: Deep Brain Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03664609?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03664609 being conducted?
This trial has 19 study locations across Arizona, California, Florida, Idaho, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.